Notably, MAT2A is essential for the survival of cancers harboring deletions of the methylthioadenosine phosphorylase (MTAP) gene, which occurs in approximately 13–15% of tumors due to its co-deletion with the CDKN2A tumor suppressor [4,5]. Here, MAT2A is linked to cancer.